XBiotech (NASDAQ: XBIT)
XBiotech Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
XBiotech Company Info
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
News & Analysis
Why XBiotech Shares Are Tumbling 23.4% Today
The company's offer to buy back shares was overtendered, resulting in a prorated deal.
Why XBiotech Shares Are Skyrocketing 32.7% Today
The company is offering to buy back shares from investors at a big premium.
This Small-Cap Biotech Gained as Much as 106.4% Today
XBiotech announced a massive deal with Johnson & Johnson subsidiary Janssen, which is thrusting the overlooked biopharma onto the radars of investors.
These 3 Biotechs Have Been Crushed; Is It Time to Bargain Shop?
Disappointing trials from XBiotech, Merrimack Pharmaceuticals, and NewLink Genetics have earned the market's ire. But are their declines overdone?
Why XBiotech Inc Jumped Higher Today
Investors are focused on the wrong data.
Why XBiotech Inc. Got Crushed Today
A European approval seems unlikely.
Why XBiotech Inc. Fell 33% Today
Without much to go on, investors wonder how well the biotech's colon-cancer drug Xilonix works.
Why XBiotech Inc. Made a U-Turn Today
Positive data despite clinical trial irregularities.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.